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Abstract A checklist is an effective implementation tool, but
addressing barriers that might impact on the effectiveness of
its use is crucial. In this paper, we explore barriers to the
uptake of an antibiotic checklist that aims to improve antibi-
otic use in daily hospital care. We performed an online ques-
tionnaire survey among medical specialists and residents with
various professional backgrounds from nine Dutch hospitals.
The questionnaire consisted of 23 statements on anticipated
barriers hindering the uptake of the checklist. Furthermore, it
gave the possibility to add comments. We included 219 com-
pleted questionnaires (122 medical specialists and 97 resi-
dents) in our descriptive analysis. The top six anticipated bar-
riers included: (1) lack of expectation of improvement of an-
tibiotic use, (2) lack of expected patients’ satisfaction by
checklist use, (3) lack of feasibility of the checklist, (4) nega-
tive previous experiences with other checklists, (5) the com-
plexity of the antibiotic checklist and (6) lack of nurses’ ex-
pectation of checklist use. Remarkably, 553 comments were
made, mostly (436) about the content of the checklist. These
insights can be used to improve the specific content of the
checklist and to develop an implementation strategy that ad-
dresses the identified barriers.
Background
A better use of current antibiotic agents is necessary to help
control antimicrobial resistance (AMR) [1]. Antibiotic stew-
ardship programs (ASPs) are introduced to coordinate activi-
ties to measure and improve appropriate antibiotic use in daily
hospital practice [2]. Recently, a set of generic quality indica-
tors (QIs) was developed tomeasure appropriate antibiotic use
in the treatment of bacterial infections in adult patients
hospitalised at non-intensive care unit departments [3].
The next step is using these QIs to improve antibiotic
use in daily practice. Checklists are effective tools to improve
patient care [4–7]. For example, the use of a surgical safety
checklist resulted in an absolute risk reduction in perioperative
complications of 10.6 % [4], and a large and sustained reduc-
tion in rates of catheter-related bloodstream infections was
demonstrated after the implementation of an infection control
checklist [5]. It can, therefore, be hypothesised that the use of
an antibiotic checklist consisting of generic quality indicators
(Box 1) improves antibiotic use in the hospital. However, the
implementation of a checklist needs to be combined with an
understanding of barriers to its uptake, since it has been shown
that physicians have resistances and interferences to the use of
checklists [8, 9]. Without enough attention for such barriers
that hinder implementation, the use of a checklist may fail,
even where other studies showed striking improvements
using the same checklist [9, 10]. Ideally, potential barriers
hindering uptake are analysed before implementation, to
influence both the type and content of the implementation
activities [11]. In general, implementation can be compli-
cated by barriers concerning the innovation itself, the indi-
vidual professional, professional interactions, the patient,
t h e o rgan i s a t i on , i ncen t i ve s , r e sou rce s o r t he
socio-political context [12, 13]. Although addressing bar-
riers that influence the effectiveness of an innovation to
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improve patient care is a crucial step in the knowledge-to-
action process [14], very few barrier studies have been
done prior to checklist implementation [15].
Box 1: The antibiotic checklist based on generic quality
indicators
1 Take at least two sets of blood cultures before starting systemic
antibiotic therapy.
2 Take specimens for culture from suspected sites of infection, if
possible before starting systemic antibiotic therapy, but at the latest
after 24 hours of treatment.
3 Prescribe systemic antibiotic treatment according to the local antibiotic
guideline.
4 a. Determine renal function.
b. Adapt dose and dosing interval of systemic antibiotics to renal
function if necessary.
5 Document the antibiotic treatment in the case notes or electronic
medical record (EMR), including:
- Indication;
- Name;
- Dose;
- Interval;
- Route of administration.
6 Determine whether antibiotic therapy can be adapted as soon as
culture results become available.
7 Switch from intravenous to oral antibiotic therapy after 48–72 hours
on the basis of the clinical condition, provided that oral treatment is
adequate.a
aAdequate means:
1: When the antibiotic is available orally;
2: When oral intake and gastrointestinal absorption are
adequate;
3: Adequate in terms of diagnosis (exceptions are e.g. endo-
carditis, meningitis).
Barrier studies performed during or after checklist imple-
mentation [16–24] described barriers such as lack of under-
standing the purpose of the checklist [17], duplication with
current work [18, 19] and problems with the method of im-
plementation [24].
The present study aims to identify barriers to the uptake
of an antibiotic checklist in Dutch hospitals prior to check-
list implementation and to select implementation activities
to target the predominant barriers that obstruct checklist
uptake.
Methods
We performed an online questionnaire survey among medical
specialists and residents to explore anticipated barriers hinder-
ing the uptake of an antibiotic checklist.
Development of the antibiotic checklist barrier
questionnaire
We based our questionnaire on the Dutch validated measure-
ment instrument for determinants of innovations (MIDI),
combined with barriers found in the literature. The MIDI is
developed by the Netherlands Organisation for Applied
Scientific Research (TNO) and is meant as a tool for re-
searchers to survey determinants that influence the uptake of
an innovation [13]. Additionally, we performed a literature
search to find publications on barriers to checklist implemen-
tation and to appropriate antibiotic use. Box 2 shows the terms
we used in our search, which resulted in 168 hits in total. We
selected one book [25], three systematic reviews [12, 26, 27],
eight relevant barrier studies [15–22, 24] and four studies on
barriers to the appropriate use of antibiotics [28–31]. Based on
this information, we adapted the MIDI to fit the topic of anti-
biotic use, so we removed potential barriers that were not
relevant and added barriers that were mentioned in the litera-
ture.
Box 2: Terms for literature search
Topic Search terms in title Hits
Reviews on barriers (checklist* OR guideline*) AND
(determinant* OR barrier* OR factor*)
Filter: systematic reviews
130
Barriers to checklist
implementation
(barrier* OR facilitator* OR determinant*
OR challenge*) AND checklist*
13
Barriers to appropriate
antibiotic use
(antibiotic* OR antimicrobial* OR
antibacterial*) AND (barrier* OR
behaviour* OR attitude*) AND
(appropriate* [Title/Abstract] OR
guideline* [Title/Abstract])
25
The final online questionnaire started with a description of
the antibiotic checklist (Box 1) and was followed by 23 state-
ments on anticipated barriers related to the checklist (seven
items), the individual professional (six items), professional
interactions (seven items), the patient (two items) and to re-
sources (one item) (see Table 1 for the specific statements). To
diminish the influence of the physician’s criticisms on the
content of the checklist, statements 8 through 23 started with
the sentence “Assuming that the checklist is adapted to your
comments on its contents”. The level of agreement or dis-
agreement with the statements was measured by a six-point
Likert scale (1= ‘totally agree’ and 6= ‘totally disagree’). For
each statement, it was possible to choose a seventh option: ‘I
don’t know’.
Furthermore, physicians could criticise the separate com-
ponents of the checklist by adding comments, and there was
also space for general or organisational comments. The ques-
tionnaire was completed anonymously, but we asked for the
participant’s function, department and hospital.
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Setting and participants
To gain insight into anticipated barriers to the uptake of an
antibiotic checklist in hospitals prior to checklist implementa-
tion, physicians in nine Dutch hospitals were invited to par-
ticipate in the survey. These nine hospitals, including two
university and seven non-university hospitals, previously
agreed to participate in a cluster-randomised trial on the im-
plementation of the antibiotic checklist [32].
We visited the hospitals to inform the local antibiotic stew-
ardship team about the antibiotic checklist and the question-
naire. Following this visit, we emailed the contact physician a
link to the questionnaire, and he/she forwarded this email to
the target group. The target group consisted of specialists and
residents—with all levels of experience and various profes-
sional backgrounds—who have direct contact with and pre-
scribe antibiotics to adult patients.
Analysis
We included questionnaires in the analysis if at least half of the
statements were appraised. We excluded statements from fur-
ther analyses if ≥30 % of the participants answered ‘I don’t
know’. While taking into account whether the statement was
formulated as a barrier hindering uptake (“This checklist is a
threat to my professional autonomy”) or as a facilitator help-
ing uptake (“I expect that this checklist will improve the qual-
ity of my antibiotic prescriptions”), all answers (1 through 6)
were re-coded into dichotomous scores: anticipated barrier
‘yes’ or ‘no’. The answers ‘I don’t know’ were excluded from
the analyses. We computed frequencies and percentages and
created a top five of the statements that were most often men-
tioned as barriers.
We categorised the comments on the checklist added by the
participants. If comparable comments were mentioned three
Table 1 Survey questionnaire
and results per domain Domain N
a Yes, this is
a barrier (%)
Top five
Checklist
This checklist explains clearly what I have to do and in which order 219 3.7
This checklist is based on evidence or experts’ consensus 192 7.8
This checklist includes every step of appropriate antibiotic use in the
hospital
216 15.3
This checklist is too complex for use in daily practice 218 17.4 ☒
This checklist fits in current practices 217 10.1
The benefits of using the checklist are clear 217 13.4
This checklist is feasible for all my patients who receive IV antibiotics 216 20.8 ☒
Individual professional
This checklist is a threat to my professional autonomy 216 13.4
I expect that this checklist will improve the quality of my antibiotic
prescriptions
212 26.9 ☒
It is part of my job to use this checklist 215 16.7
I am capable of using this checklist 211 5.2
I have enough knowledge and expertise to use the checklist adequately 218 1.4
I have good previous experiences with working with a checklist 201 19.9 ☒
Professional interactions
Colleagues will support me to use this checklist 183 8.7
Supervisors will support me to use this checklist 177 6.8
Nurses will support me to use this checklist 186 9.1
Colleagues will use this checklist 191 14.7
Colleagues will expect me to use the checklist 196 10.2
Supervisors will expect me to use the checklist 179 9.5
Nurses will expect me to use the checklist 182 14.8
Patients
Patient will be satisfied that this checklist is being used 170 21.8 ☒
I expect that this checklist will improve the patient’s antibiotic treatment 212 12.3
Resources
There are enough financial resources to use the checklist as it is meant to
be used
108 of 219 (49.3 %) answered
‘I don’t know’→ exclusion
aN Number of answers after exclusion of the answers ‘I don’t know’
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times or more, the comment was considered to be relevant. We
also created a top five of comments.
Results
Participants
The online questionnaire was filled out by participants in eight
of the nine hospitals that initially agreed to participate in the
cluster-randomised trial on the implementation of the antibi-
otic checklist. One non-university hospital no longer wanted
to participate and was replaced by a similar hospital. In anoth-
er hospital, the link to the questionnaire was only emailed to
physicians of the department of infectious diseases. In total,
250 physicians participated in the survey, of which 219 par-
ticipants completed 50 % or more of the questionnaire state-
ments. These 219 questionnaires were included in the analy-
ses. The participants’ characteristics are summarised in
Table 2. The number of completed questionnaires per hospital
ranged from 8 to 90.
Barriers
Table 1 shows the survey results. The statement concerning
the availability of sufficient financial resources to use the
checklist was excluded from further analysis, as more than
30% of the participants answered ‘I don’t know’. The top five
anticipated barriers were: (1) lack of expected quality im-
provement of the physician’s antibiotic prescribing (26.9 %),
(2) lack of expected patients’ satisfaction with checklist use
(21.8 %), (3) lack of feasibility of the checklist (20.8 %), (4)
negative previous experiences with other checklists (19.9 %)
and (5) the complexity of the antibiotic checklist (17.4 %).
To exclude the possibility that the single hospital in which
90 physicians completed the questionnaire influenced the re-
sults disproportionally, we compared the appraisals of the 219
participants (nine hospitals) with the appraisals of 129 partic-
ipants (eight hospitals). The top five anticipated barriers from
these eight hospitals differed on one statement: instead of
‘complexity of the checklist’, the statement ‘nurses will expect
me to use the checklist’ was in the top five. For this reason,
this barrier was added to the list of frequently mentioned bar-
riers (6). This top six contains barriers from four different
domains, namely the individual professional (1 and 4), the
patient (2), the checklist (3 and 5) and professional interac-
tions (6).
Comments
In total 553, comments were given, of which 436 were com-
ments and suggestions regarding the content of the checklist,
59 were general comments and 58 were organisational com-
ments. These organisational comments described contextual
factors that should be taken into account in these specific
hospitals, i.e. implementation of a new electronic medical re-
cord (EMR) system (14.6 %) and merger of the hospital with
another hospital (7.3 %). Comments on the content of the
checklist or general comments that were relevant for all hos-
pitals and were mentioned at least three times are presented in
Table 3. The five most frequently mentioned comments were:
(1c) “the item documentation leads to duplication of work”
(11.0 %), (2c) “doubts about the need of blood cultures for
several diagnoses” (10.5 %), (3c) “incomplete or too simplis-
tic clarification of ‘adequate in terms of diagnosis’ for the item
IV o oral switch” (8.2 %), (4c) “add information about the
renal function” (6.8 %) and (5c) “add that one should take
different sites for taking two different blood cultures”
(6.4 %). Again, we compared the overall top five with the
top five after exclusion of the 90 questionnaires of the single
(university) hospital, which showed that the top five of the
eight hospitals was equal to the overall top five comments.
Addressing identified barriers
We developed an implementation strategy that could be ap-
plied in all hospitals to address the top six anticipated barriers.
The barrier (1) “lack of expected quality improvement of
the physician’s antibiotic prescribing” can be addressed in the
following two ways: first by showing the room for improve-
ment, i.e. giving feedback on their current antibiotic use based
on a baselinemeasurement, and second by providing evidence
for a reduction in the length of hospital stay for the patient
with adequate antibiotic use [33]. This information can be
Table 2 Participants’ characteristics (n= 219)
n
University/non-university 104/115
Specialists/residents 122/97
Specialties
Internal medicine, gastroenterology and pulmonology 125
General surgery 27
Neurology 23
Emergency department 15
Urology 9
Gynaecology 5
Plastic surgery 3
Oral and maxillofacial surgery 3
Ear, nose and throat 2
Anaesthesia 2
Microbiology 2
Ophthalmology 1
Orthopaedic surgery 1
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given during a kick-off lecture at the departments that partic-
ipate in the cluster-randomised trial on the implementation of
the antibiotic checklist [32].
The barrier (2) “lack of expected patients’ satisfaction with
checklist use” can be addressed by giving information about
the study at the nursery department, i.e. by supplying flyers
about antimicrobial resistance and the expected effects of ap-
propriate antibiotic use [33].
Two anticipated barriers, namely (3) “the feasibility of the
checklist” and (5) “the complexity of the checklist”, can be
addressed by adapting the checklist. Table 4 shows the
adapted checklist based on the survey results, which includes
tick boxes and pre-printed options.
To address the barrier (4) “negative previous experiences
with other checklists”, the differences between these previous
checklists (most probably the surgical safety checklist) and
this antibiotic checklist should be emphasised, for example
in group discussions. Differences are, e.g. that this checklist
is short and does not involve other physicians to complete it.
In addition, it should be stressed that the antibiotic checklist
was adapted based on their comments and the comments of
other colleagues participating in the trial.
Table 3 Comments per checklist item
Checklist item Comment mentioned at least three times Nb Top five
Blood cultures (n= 88)a Doubts about the need of blood cultures for several diagnoses (e.g. cellulitis) 23 ☒
Add in the checklist that one should take different sites for the two cultures 14 ☒
Logistically difficult because of lack of time 10
Doubts about the cost-effectiveness 10
Blood cultures should only be taken if the patient has fever 8
In which situation should you take more than two blood cultures? 8
Add in the checklist how long the period should be between the two cultures 6
This causes delay in the start of treatment in patients with a suspicion of bacterial
meningitis
4
Make clear that one set exists of an aerobic and an anaerobic bottle 3
Culture of suspected site of infection
(n = 43)a
Only if possible 12
The mentioned timeframe for taking the culture (<24 h) causes confusion 9
This may delay the start of treatment 4
If there is no suspected site of infection, a urine culture is always indicated 3
Prescribing antibiotics according to
the hospital guidelines (n = 68)a
Add a link to the guidelines 10
It is not clear what is meant by hospital guidelines, e.g. some departments have
their own protocols. Do these count as guidelines?
5
If previous culture results are available, these should be taken into account 4
Why not use national guidelines as a first choice? 3
Adapt to renal function (n= 46)a Provide the normal range for renal function, or provide criteria for adaptation, or
add a link to these criteria
15 ☒
Adaptation should only be done if necessary 4
Documentation (n= 70)a Duplication with documentation in existing electronic medical record 24 ☒
Add the intended duration of treatment 3
Adaption based on culture results
(n = 63)a
There is often delay in the culture results 6
What to do if cultures are negative or not taken? 4
Not always feasible (immunocompromised patients, patients with cystic fibrosis,
suspected joint prosthesis infection)
3
Switch IV to oral treatment (n= 58)a Item **3) ‘adequate in terms of diagnosis’ is not complete or too simplistic 18 ☒
It is not clear when and how to switch 6
This depends on the culture results 3
General comments (n= 59)a The checklist is not innovative 8
The item ‘antibiotic allergy’ is missing 8
Worries about extra administrative work for physicians 6
The need for careful implementation 5
The checklist is not feasible in all situations 4
Is this checklist evidence based? 3
a Total number of comments on this checklist item
b Total number of participants who gave this comment
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Table 4 The final antibiotic checklist
Phase 1: the start of 
intravenous antibiotic 
treatment 
Yes No
1
Take at least two sets of 
blood cultures from two 
different puncture sites 
before starting antibiotic  
therapy
In my opinion, not necessary with this diagnosis
Cultures have been taken < 1 week ago
………………………………………………………….
2
Take specimens for culture 
from suspected sites of 
infection
No culture possible 
Cultures have been taken < 1 week ago
………………………………………………………….
3
Prescribe systemic 
antibiotic treatment 
according to the local 
antibiotic guideline
According to other guideline, namely ……………..
Allergy
Treatment based on previous culture results
.      ………………………………………………………….
4
a. Determine renal function
…   ………………………………………………………....
b. Adapt dose and dosing 
interval of antibiotic to renal 
function 
Not applicable 
………………………………………………………….
5
Document the indication for 
the antibiotic treatment in 
the case notes or electronic 
medical record (EMR)
………………………………………………………….
Phase 2: after 48-72 hours of 
treatment
Yes No
6
Adapt therapy when culture 
results become available
………………………………………………………….
7 
Switch from intravenous to 
oral antibiotic therapy after 
48 -72 hours
Insufficient clinical improvement. 
No oral antibiotic available
No adequate oral intake/ gastrointestinal absorption
No oral therapy possible with this diagnosis ………
…………………………………………………………….
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Finally, to address the barrier (6) “lack of nurses’ expecta-
tion of checklist use”, nurses working at participating depart-
ments should be informed about the checklist use and its aims,
for example through email, e-learnings and/or the department
lecture showing the room for improvement and the evidence
for reduction in the length of hospital stay for the patient with
adequate antibiotic use.
Incorporating comments
We adapted the checklist design based on the top five com-
ments. First (1c), to reduce duplication of documentation, we
left out the name, dose, interval and route of administration of
the antibiotic, and the item was reduced to ‘documentation of
indication’. This is appropriate since all Dutch hospitals are,
nowadays, obliged to work with an electronic medical record
that already requires this information. Second (2c), since
10.5 % of the participants felt that taking blood cultures was
not necessary for all diagnoses, we added the option “In my
opinion, not necessary with this diagnosis” in the checklist.
Third (3c), we left out the clarification of “adequate in terms of
diagnosis” for the item IV to oral switch, and included options
in the checklist so that the physicians could tick their reasons
for not switching: “Insufficient clinical improvement”; “No
oral antibiotic available”; “No adequate oral intake/
gastrointestinal absorption” and “No oral therapy possible
with this diagnosis”. In addition, we ensured that the informa-
tion on switch criteria could be easily found: we developed
informative posters and laminated pocket versions of the
checklist, which included a reference to the website with all
necessary information concerning this topic. The information
about dosage adaptation when the patient has an impaired
renal function (4c) can also be found on this website. Last
(5c), we added in the checklist that, for taking two different
blood cultures, one should use two different sites.
Discussion
In this study, we identified the barriers that need to be ad-
dressed when implementing an antibiotic checklist. We creat-
ed a top six of anticipated barriers to the uptake of the check-
list, and a top five of comments on its components. The top six
barriers encompassed four different domains, namely barriers
related to the individual professional, to the patient, to profes-
sional interactions and to the checklist itself. The top five
comments mostly encompassed suggestions to more clearly
specify the content of the checklist, i.e. the quality indicators
included. We adapted the checklist to the survey results; two
barriers and all top five comments could be addressed by
adapting the design of the checklist, and by re-phrasing vari-
ous checklist items (Table 4).
Our most frequently mentioned barrier, the lack of expect-
ed improvement of care, has been described by several other
barrier studies of checklist implementation [17, 18, 20].
Feasibility is also a known barrier in the implementation of
checklists; items in the surgical safety checklist were per-
ceived to be inappropriate for certain surgical procedures
[16] or for certain settings [18]. Patient perceptions were only
mentioned as a barrier by Russ et al., describing that too many
checks can create anxiety and unsafe feelings towards the
system [16]. This might be an explanation of our anticipated
barrier “lack of patient’s satisfaction”. However, this anticipat-
ed barrier can also be explained by the fact that our antibiotic
checklist is typically meant as a reminder for physicians; in
daily practice, patients probably will not notice the use of the
checklist. Next, the literature describes barriers comparable to
our sixth anticipated barrier, “lack of nurses’ expectation of
checklist use”, since it is associated with both the lack of
teamwork [20, 21, 23, 24] and professional hierarchy [17,
18]. Not surprisingly, the barrier “negative previous experi-
ences with other checklists” was not mentioned in previous
studies, as those evaluations were performed after the intro-
duction of the checklists, and our inventory was performed
before checklist implementation. The complexity of the
checklist was once earlier described as a barrier after the im-
plementation of a quality improvement checklist on an inpa-
tient hepatology service [21]. It was, however, not a major
barrier, as it was only mentioned by 1 of the 23 participants.
The explanation for why this is a top five barrier in our survey
and not in previous studies might be that other barrier studies
have been done during or after checklist implementation. In
that phase, the physicians’ main concerns are the
organisational problems they are facing in daily practice and,
consequently, these studies mainly describe logistic barriers,
such as difficulties in timing (when to fill out the checklist)
and lack of time [16–19, 21, 24], and professional barriers
such as lack of senior support and professional hierarchy
[17, 18, 20, 24]. We identified the barriers before implemen-
tation of the checklist, and the physicians, therefore, may have
felt that they still had an influence on the contents and design
of the checklist. Finally, it appears that the benefit of the use of
checklists is not always clear [17–19] and a lack of under-
standing of the purpose of the checklist might influence its
use [17]. This topic was, however, not mentioned as a barrier
in our study.
The current study has some strengths. To our knowledge,
our study is the first to assess and quantify barriers prior to
checklist implementation. We based our questionnaire on a
validated instrument to measure determinants of innovations,
combinedwith a literature search. The barriers to the uptake of
the antibiotic checklist were reported by a large sample of
physicians from nine different hospitals. Furthermore, we in-
cluded residents and specialists of surgical departments and
medical departments, while previous barrier studies only
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focussed on people in the surgical [16, 18–20, 23, 24] or
medical fields [15, 17, 21]. Finally, barrier identification prior
to implementation resulted not only in the identification of
concerns about the structure of the checklist and the introduc-
tion into the clinical workflow, but also concerns about the
actual content of the checklist. Although the set of quality
indicators has been developed in a RAND-modified Delphi
procedure by experts [3], the comment “doubts about the need
of blood cultures for several diagnoses” (2c) expresses dis-
agreement among physicians about targeting “taking blood
cultures” in the checklist. Disagreement about clinical mea-
sures targeted in the checklist can hinder implementation.
Therefore, the option “no, in my opinion, not necessary with
this diagnosis” was added in the checklist. The cluster-
randomised trial [32] will show how often this option in the
checklist will be used, and can help to determine whether
taking blood cultures is part of agreed-upon standard
concerning appropriate antibiotic use among frontline
clinicians.
The most important limitation of our study is that the phy-
sicians of one university hospital completed 90 of the 219
questionnaires. We compared, however, the appraisals of the
219 participants (nine hospitals) with the appraisals of 129
participants (eight hospitals). This comparison resulted in the
addition of a sixth anticipated barrier on nurses’ expectations
regarding checklist use. During the implementation process,
this barrier should also be addressed. A second limitation has
to do with the chosen recruitment method. We emailed the
contact physician a link to the questionnaire, and asked him/
her to forward this email to the target group. Through this
approach, we aimed to invite as many professionals as possi-
ble to participate in the questionnaire study. The downside of
this approach is that the exact number of physicians that re-
ceived the link to the questionnaire was unclear and, conse-
quently, that it was impossible to determine the response rate.
Based on an analysis in one hospital where we could retrieve
information on the number of invitations sent, we estimated
the response rate to be about 30 %, which is also found in
other studies [34, 35]. Although the response rate is said to be
important to determine the non-response bias, Willis et al.
showed that increasing the response rate by additional re-
contacts had little effect on the key data distribution and, there-
fore, they suggest in physician surveys to have a larger initial
sample (as we did) and to accept a lower final overall response
rate [36]. Furthermore, a barrier study prior to implementation
also has its limits, as the appraisers lack experience in actually
using the checklist. Finally, although the contents of our ques-
tionnaire were carefully chosen, some results might seem less
informative after all. For the anticipated barrier concerning
negative previous experiences, it remains unclear whether
the problem with other checklists concerned, for example,
the length of the checklist, the lack of time or no perceived
benefit. Explicitly discussing this barrier in small groups of
physicians—as suggested—might, however, provide insight
into the underlying problem.
Performing a barrier analysis prior to checklist implemen-
tation creates the opportunity to address barriers in an early
stage, and to adapt its design structure and content. This iter-
ative survey resulted in a checklist adapted to the perceptions
of frontline clinicians, which should facilitate implementation.
The results of our barrier analysis may be specific for our
setting and our checklist. Since our developed questionnaire
is based, however, on a validated instrument and a literature
search, we assume that the checklist questionnaire itself can be
used for barrier identification for the implementation of other
checklists.
This survey provides insight into the anticipated barriers
that have to be addressed when implementing an antibiotic
checklist in Dutch hospitals. Taking into account these factors
that hinder the uptake of the antibiotic checklist, implementa-
tion in daily practice will be challenging. Education, feedback,
involvement of the whole healthcare team in the implementa-
tion process and adaption of the checklist itself (Table 4) will
be necessary to overcome the barriers hindering the uptake of
the checklist and to improve the appropriate use of antibiotics.
Our assumption that the suggested combination of interven-
tions should facilitate successful checklist implementation
will be tested in a cluster-randomised trial [32].
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